These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9480031)
1. GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster. Matsuno H; Kozawa O; Niwa M; Kaida T; Hayashi H; Uematsu T Br J Pharmacol; 1997 Nov; 122(6):1099-104. PubMed ID: 9480031 [TBL] [Abstract][Full Text] [Related]
2. Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster. Matsuno H; Kozawa O; Niwa M; Ito T; Tanabe K; Nishida M; Hayashi H; Uematsu T J Cardiovasc Pharmacol; 1998 Aug; 32(2):191-7. PubMed ID: 9700979 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011 [TBL] [Abstract][Full Text] [Related]
4. Neointima formation in injured hamster carotid artery is effectively prevented by the combination G4120 and quinapril. Matsuno H; Stassen JM; Moons L; Vermylen J; Hoylaerts MF Thromb Haemost; 1996 Aug; 76(2):263-9. PubMed ID: 8865543 [TBL] [Abstract][Full Text] [Related]
5. Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapidil and captopril. Matsuno H; Stassen JM; Hoylaerts MF; Vermylen J; Deckmyn H Thromb Haemost; 1995 Dec; 74(6):1591-6. PubMed ID: 8772242 [TBL] [Abstract][Full Text] [Related]
6. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery. Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the antithrombotic effects and bleeding risk of fractionated aurin tricarboxylic acid and the GPIIb/IIIa antagonist GR144053 in a hamster model of stenosis. Ito T; Matsuno H; Kozawa O; Niwa M; Sakai N; Uematsu T Thromb Res; 1999 Jul; 95(1):49-61. PubMed ID: 10403686 [TBL] [Abstract][Full Text] [Related]
8. Alpha 1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury. Fingerle J; Sanders KH; Fotev Z Basic Res Cardiol; 1991; 86 Suppl 1():75-81. PubMed ID: 1674657 [TBL] [Abstract][Full Text] [Related]
9. Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Matsuno H; Kozawa O; Nagashima S; Kanamaru M; Uematsu T Br J Pharmacol; 1999 Jul; 127(5):1129-34. PubMed ID: 10455258 [TBL] [Abstract][Full Text] [Related]
10. Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injury. Lemay J; Hamet P; deBlois D J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):46-50. PubMed ID: 11967799 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated. van Kleef EM; Fingerle J; Daemen MJ Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):857-63. PubMed ID: 8673560 [TBL] [Abstract][Full Text] [Related]
12. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Choi ET; Khan MF; Leidenfrost JE; Collins ET; Boc KP; Villa BR; Novack DV; Parks WC; Abendschein DR Circulation; 2004 Mar; 109(12):1564-9. PubMed ID: 15007005 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice. Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application. Taguchi J; Abe J; Okazaki H; Ochiai M; Ohno M; Takuwa Y; Kurokawa K Biochem Biophys Res Commun; 1993 Oct; 196(2):969-74. PubMed ID: 8240375 [TBL] [Abstract][Full Text] [Related]
15. Neointimal-specific induction of apoptosis by losartan results in regression of vascular lesion in rat aorta. Lemay J; Hale TM; deBlois D Eur J Pharmacol; 2009 Sep; 618(1-3):45-51. PubMed ID: 19619526 [TBL] [Abstract][Full Text] [Related]
16. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Kauffman RF; Bean JS; Zimmerman KM; Brown RF; Steinberg MI Life Sci; 1991; 49(25):PL223-8. PubMed ID: 1745100 [TBL] [Abstract][Full Text] [Related]
17. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury. Moon MC; Molnar K; Yau L; Zahradka P J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery. Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855 [TBL] [Abstract][Full Text] [Related]
19. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of low-dose estrogen on neointimal formation after balloon injury of rat carotid artery. Watanabe T; Miyahara Y; Akishita M; Nakaoka T; Yamashita N; Iijima K; Kim H; Kozaki K; Ouchi Y Eur J Pharmacol; 2004 Oct; 502(3):265-70. PubMed ID: 15476753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]